Description
Noggin is a secreted homodimeric glycoprotein that is an antagonist of bone morphogenetic proteins (BMPs), Noggin antagonizes the biological activity of BMP by blocking the binding of BMP to type I and II receptors. Noggin shows a high affinity to BMP4 but a low affinity to BMP7. During embryogenesis, Noggin antagonizes specific BMPs at defined times, for example, during neural tube, somite and cardiomyocyte growth and patterning. During bone development, Noggin prevents chondrocytes from proliferating so as to allow normal joint formation. During culture of human embryonic stem cells (hESC) or neural stem cells under certain conditions, addition of Noggin to antagonize BMP activity may allow stem cells to proliferate while maintaining their undifferentiated state, or alternatively, to differentiate into dopaminergic neurons. Noggin is expressed in defined areas of the adult central nervous system and peripheral tissues such as lung, skeletal muscle and skin.
Recombinant Human Noggin is expressed by mammalian cells, and is produced with raw materials of pharmaceutical applicable level. The host protein residue, nucleic acid residue and common pathogens are strictly controlled, and the production and quality management procedures of the product comply with GMP regulations to ensure the traceability of the production process and all raw materials.
Usage
In-vitro cultivation of various types of cells.
Quality Control
| Item | Standard |
| Appearance | White porosity |
| Reconstitution | Totally dissolve in stated time |
| Visible particle | Conform to ChP |
| pH value | 6.9–7.9 |
| Purity | ≥ 95% |
| Bioactivity | 10–100 ng/mL |
| Endotoxin | < 10 EU/mg |
| Host protein | ≤ 0.005% |
| Exogenous DNA residue | ≤ 100 pg/mg |
| Mycoplasma test | Negative |
| Sterility test | Conform to ChP |
Product Details
| Item | Details |
| Storage | Storage at -20±5℃, expiration date labeled on bottle. |
| Recommendations | (1)Make sure the product properly stored and none expired before using. (2)Please use water for injection for reconstitution, to a concentration > 100 μg/ml. (3)Sterile condition without pyrogen is required for reconstitution, re-aliquoting, dilution. (4)After reconstitution, aliquoted solution vials should be stored at -70°C and minimize freeze-thaw cycles preventing denaturation of protein. |
title: NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer
authors: Xiduan Wei, Li Yang, Yuting Wang, Kun Wang, Dan Wang, Mengqian Gao, Xinhua Liu, Xuerui Yang, Suhua Wang, Yiran Zheng, Chunting Wang, Lifang Zhang, Wenjun Yu, Jiawei Wang, Dan Yang, Gang Liu, Yao Ma
date: 2026/07/16
journal: Signal Transduction and Targeted Therapy
title: Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation
authors: Wang Yan, Zhang Zilin, Li Xiaoran, Lu Xiaobing, Zhuansun Xuemei, Li Qiwei, Zhang Jing, Xu Xi, Liu Xueqiang, Wei Yuan, Hua Feng, Wu Runda, Chen Zaozao
date: 2025/03/05
journal: In vitro models
MDSD